» Authors » Jonas Wanninger

Jonas Wanninger

Explore the profile of Jonas Wanninger including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 4
Citations 1583
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Nakamura T, Mishima E, Yamada N, Mourao A, Trumbach D, Doll S, et al.
Nat Struct Mol Biol . 2023 Nov; 30(11):1806-1815. PMID: 37957306
Ferroptosis, marked by iron-dependent lipid peroxidation, may present an Achilles heel for the treatment of cancers. Ferroptosis suppressor protein-1 (FSP1), as the second ferroptosis mainstay, efficiently prevents lipid peroxidation via...
2.
Nakamura T, Hipp C, Mourao A, Borggrafe J, Aldrovandi M, Henkelmann B, et al.
Nature . 2023 Jun; 619(7969):371-377. PMID: 37380771
Ferroptosis is evolving as a highly promising approach to combat difficult-to-treat tumour entities including therapy-refractory and dedifferentiating cancers. Recently, ferroptosis suppressor protein-1 (FSP1), along with extramitochondrial ubiquinone or exogenous vitamin...
3.
Mishima E, Ito J, Wu Z, Nakamura T, Wahida A, Doll S, et al.
Nature . 2022 Aug; 608(7924):778-783. PMID: 35922516
Ferroptosis, a non-apoptotic form of cell death marked by iron-dependent lipid peroxidation, has a key role in organ injury, degenerative disease and vulnerability of therapy-resistant cancers. Although substantial progress has...
4.
Doll S, Porto Freitas F, Shah R, Aldrovandi M, Costa Da Silva M, Ingold I, et al.
Nature . 2019 Oct; 575(7784):693-698. PMID: 31634899
Ferroptosis is an iron-dependent form of necrotic cell death marked by oxidative damage to phospholipids. To date, ferroptosis has been thought to be controlled only by the phospholipid hydroperoxide-reducing enzyme...